CAS 194090-67-0: 9H-Xanthen-9-one,3,6,8-trihydroxy-2-methoxy-1,4,7-tris(3-methyl-2-butenyl)-

7-O-Methylgarcinone E is a bioactive compound, specifically a xanthone derivative, which is sourced from various Garcinia species, a genus of tropical trees and shrubs. This compound is structurally characterized by its xanthone core and the presence of a methoxy group at the seventh position, contributing to its biological activity. The mode of action of 7-O-Methylgarcinone E is linked to its ability to modulate oxidative stress and exhibit cytotoxic effects on certain cancer cell lines. It operates by interfering with cellular pathways that regulate apoptosis and proliferation, potentially leading to reduced tumor growth and enhanced cancer cell death. In terms of applications, 7-O-Methylgarcinone E is primarily explored within the realm of medical research, particularly in the development of novel anticancer therapies. Its unique properties make it a candidate for in-depth studies aimed at understanding its potential as a therapeutic agent against various forms of cancer. Beyond oncology, its antioxidant capabilities present possibilities for broader applications in managing oxidative stress-related diseases. Overall, it serves as a promising compound for ongoing research in pharmacology and biotechnology.